Wan Gi Kim
27Patents
4h-index
44Co-inventors
59Inventor score
Filing activity: Sep 20, 1999 → Nov 21, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6232712A | Cathode ray tube having specific thickness ratio | Electricity | 12 | Expired |
| US6437496B1 | Tensioned shadow mask and color cathode ray tube adopting the same | Electricity | 10 | Expired |
| US6380668B1 | Cathode ray tube | Electricity | 5 | Expired |
| US6274977A | Cathode ray tube with specifically shaped panel | Electricity | 4 | Expired |
| US6348758B1 | Flat type color cathode ray tube | Electricity | 2 | Expired |
| US6407496B2 | Cathode ray tube | Electricity | 2 | Expired |
| US6472806B1 | Tensioned shadow mask for cathode ray tube including tie bars having dummy bridges | Electricity | 2 | Expired |
| US9192597B2 | Composition for inhibiting vascular aging comprising syringaresinol | Human Necessities | 1 | Active |
| US10555983B2 | Composition for brain activation, comprising ginseng fruit extract | Human Necessities | 1 | Active |
| US8652538B2 | Composition for accelerating change in muscle type | Human Necessities | 1 | Active |
| US6580204B1 | Hook assembly for use in shadow mask frame assembly | Electricity | 1 | Expired |
| US10383904B2 | Composition for improving health and quality of life of women containing ginseng berry extract | Human Necessities | 0 | Active |
| US8536154B2 | Composition for activating mitochondria | Human Necessities | 0 | Active |
| US10912809B2 | Enhancer for catechin uptake in enterocytes | Human Necessities | 0 | Active |
| US9011940B2 | Bitter-taste inhibitor and ginseng composition comprising same | Human Necessities | 0 | Active |
| US11975037B2 | Composition for preventing, alleviating or treating burnout syndrome | Human Necessities | 0 | Active |
| US9913823B2 | SIRT 1 activator including syringaresinol | Human Necessities | 0 | Active |
| USRE41233E1 | Cathode ray tube | General | 0 | Expired |
| US6614162B2 | Panel of cathode ray tube | Electricity | 0 | Expired |
| US8652542B2 | Composition for preventing or treating arteriosclerosis | Human Necessities | 0 | Active |
| US9999611B2 | SIRT 1 activator including syringaresinol | Human Necessities | 0 | Active |
| US10022351B2 | SIRT 1 activator including syringaresinol | Human Necessities | 0 | Active |
| US9084785B2 | Composition for accelerating change in muscle type | Human Necessities | 0 | Active |
| US11096921B2 | SIRT 1 activator including syringaresinol | Human Necessities | 0 | Active |
| US9795583B2 | Composition for preventing or treating heart disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.